1. Behavioural effect of L-dopa in schizophrenic patients;Angrist, B.; Sathananthan, G.; Gershon, S.;Psychopharmacologia (Berlin),1973
2. Apomorphine in Parkinsonian tremor;Braham, J.; Sarova-Pinhas, I.; Goldhammer, Y.;British Medical Journal,1970
3. Effect of acute and chronic neuroleptic therapy on serum prolactin levels in men and women of different age groups;De Rivera, J.L.; Lal, S.; Ettigi, P.; Hontela, S.; Muller, H.F.; Friesen, H.G.;Clinical Endocrinology,1976
4. Human prolactin;Daughaday, W.H.; Jacobs, L.S.;Ergebnisse der Physiologie,1972
5. Injected apomorphine and orally administered levodopa in Parkinsonism;Diiby, S.E.; Cotzias, G.C.; Papavasiliou, P.S.; Lawrence, W.H.;Archives ofNeutrology (Chic.),1972